Galderma R&d
Clinical trials sponsored by Galderma R&d, explained in plain language.
-
New acne cream shows promise in large chinese trial
Disease control Recruiting nowThis study tests a prescription cream called trifarotene for moderate acne on the face and upper body. About 561 Chinese participants aged 9 and older will apply the cream daily for 12 weeks. The goal is to see if it clears acne better than a cream with no active ingredient.
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
New drug trial aims to harden skin Disease's grip
Disease control Recruiting nowThis study tests a drug called nemolizumab in adults with systemic sclerosis, a disease that causes skin thickening and organ damage. The goal is to see if the drug can reduce skin hardness and find the best dose. About 162 participants will receive either nemolizumab or a placeb…
Phase: PHASE2 • Sponsor: Galderma R&D • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New eczema drug tested in real-world settings on 1,000 patients
Disease control Recruiting nowThis study is tracking 1,000 teens and adults with moderate-to-severe atopic dermatitis (eczema) who are starting nemolizumab as part of their normal medical care. Researchers want to see how well the drug controls skin symptoms and itching after 6 months, using both doctor ratin…
Sponsor: Galderma R&D • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New study tests injections for smoother skin
Symptom relief Recruiting nowThis study tests if Restylane Skinboosters Vital Lidocaine can improve facial skin quality, like reducing fine lines. About 171 Chinese adults aged 18 and older will either get the treatment or no treatment. The main goal is to see if treated skin looks better after a set time.
Phase: NA • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated May 26, 2026 08:53 UTC
-
New study tests nemolizumab for severe itch in Real-World patients
Symptom relief Recruiting nowThis study looks at how well the drug nemolizumab works for adults with moderate-to-severe prurigo nodularis, a skin condition that causes intense itching and bumps. Researchers will track 600 patients over 6 to 12 months to see if their itch and skin lesions improve. The goal is…
Sponsor: Galderma R&D • Aim: Symptom relief
Last updated May 26, 2026 08:52 UTC
-
New drug targets mysterious chronic itch in 50-Patient trial
Symptom relief Recruiting nowThis study tests a drug called nemolizumab in 50 adults who have had chronic itching for at least 6 months with no clear cause. The goal is to see how the drug moves through the body and how well it reduces itching over 16 weeks. Participants must be 18 or older and have itching …
Phase: PHASE2 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated May 26, 2026 08:34 UTC
-
New imaging study reveals how wrinkle treatment reshapes skin
Knowledge-focused Recruiting nowThis study aims to understand how a biostimulator treatment called Sculptra changes the structure of the skin in the cheek area. Researchers will use special cameras and imaging tools to compare skin before and after treatment. The study involves 25 women aged 45 to 65 with moder…
Phase: NA • Sponsor: Galderma R&D • Aim: Knowledge-focused
Last updated May 26, 2026 08:54 UTC
-
Menopause skin study: can a wrinkle treatment change your skin at the cellular level?
Knowledge-focused Recruiting nowThis study looks at how a treatment called poly L-lactic acid (PLLA) changes skin proteins in women going through different stages of menopause. Forty women with moderate to severe cheek wrinkles will receive the treatment, and small skin samples will be taken to see what happens…
Phase: NA • Sponsor: Galderma R&D • Aim: Knowledge-focused
Last updated May 26, 2026 08:19 UTC